Integrated BioPharma Inc. (OTCMKTS:INBP – Get Free Report) saw a significant increase in short interest in August. As of August 31st, there was short interest totaling 4 shares, an increase of ∞ from the August 15th total of 0 shares. Based on an average daily trading volume, of 12,617 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are sold short.
Integrated BioPharma Price Performance
Shares of OTCMKTS INBP opened at $0.17 on Thursday. The business has a 50-day moving average of $0.17 and a two-hundred day moving average of $0.21. The company has a market capitalization of $5.27 million, a price-to-earnings ratio of -2.43 and a beta of 0.40. Integrated BioPharma has a 1 year low of $0.14 and a 1 year high of $0.42.
About Integrated BioPharma
Featured Stories
- Five stocks we like better than Integrated BioPharma
- IonQ and NVIDIA Just Cracked a Major Quantum Computing Bottleneck
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
